CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

BrainChild hauls in $116M to make cell therapies for childhood brain cancers

Positive
AI Analysis

Summary

BrainChild, a spinout from Seattle Children's Hospital, raised $116M in funding to advance a CAR-T cell therapy for rare and deadly childhood brain cancers into mid-stage clinical testing.

Clinical Trial Data

Phase

Phase 2

Importance:6/10
Sentiment:
0.70
cell_therapyCAR-Tpediatric_cancerfundingspinout
Related Companies

Read the original article

Published by BioPharma Dive on September 8, 2026 11:00 AM

Read Original